期刊文献+

基于参考实验室网络定值的人血清样本量值传递效果评价 被引量:2

Investigations on the effect of measuring value transfer for human serum samples assigned by the reference laboratory network
下载PDF
导出
摘要 目的研究基于参考实验室网络定值的人血清样本对改进临床实验室丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、γ-谷氨酰基转移酶(GGT)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、α-淀粉酶(Amy)、碱性磷酸酶(ALP)等7个酶学指标量值传递的效果。方法依托华北、华南、华东、西南4个区域的5家参考实验室辐射区域内的各级医疗机构,建立相应的常规实验室量值传递/溯源网络;北京航天总医院提供互换性良好、具有标准物质特性的冰冻人血清样品(校准品、评估样品1、评估样品2),由4个区域5家参考实验室联合赋值;将样品发送至全国48家实验室,各实验室按各自的标准操作规程先测量2个评价样品,再用提供的冰冻人血清样品作为校准品校准厂家系统后再次测量2个评价样品,依据WS/T 403-2012卫生行业标准判断各实验室测量结果正确度的变化,ALT、AST观察结果一致性的变化。结果 Amy、ALP、GGT、CK、LDH的校准品、样品1及样品2网络定值结果分别为138.7 U/L、278.5 U/L、68.3 U/L,265.3 U/L、94.5 U/L、134.4 U/L,195.8 U/L、89.0 U/L、158.9 U/L,393.7U/L、260.0 U/L、645.3 U/L,302.0 U/L、250.0 U/L、452.7 U/L;常规测量系统Amy、ALP、GGT量值传递前样品1及样品2满足WS/T 403-2012偏移要求的百分率分别为65.9%、61.0%,76.6%、78.7%,66.7%、70.8%,量值传递后分别为89.2%、83.8%,86.7%、80.0%,85.4%、91.7%,CK、LDH量值传递前样品2满足行标要求的百分率为64.6%、58.3%,量值传递后为93.5%、84.8%;ALT、AST实验室常规测量系统量值传递前后一致性:量值传递前样品1及样品2为12.9%、11.3%,10.2%、8.9%,量值传递后为9.3%、8.2%,5.6%、5.9%。结论基于参考实验室网络定值人血清样本建立的校准常规系统量值传递路径明显提高了我国各级医疗机构临床实验室Amy等7个酶学项目检验结果的可比性,值得进一步推广。 Objective To investigate the effect of measuring value transfer for human serum samples assigned by the reference laboratory network on improving the trueness of seven enzyme activities in clinical laboratories,such as ALT,AST,GGT,LDH,CK,AMY and ALP.Methods Depending on the medical institutions at all levels contacted by 5 reference laboratories in North China,South China,East China and Southwest China,the corresponding clinical laboratory measuring value transfer/traceability network was established. The frozen human serum samples with good interchangeability and standard material characteristics,including calibrator,sample 1 and sample 2,were provided by Beijing Aerospace General Hospital,and were assigned by 5 reference labotatories in four regions. These samples were sent to 48 clinical laboratories. These clinical laboratories measured sample 1 and sample 2 according to their standard operating procedures,and then measured the two samples again after adjusting their measurement system by using the supplied calibrator. The changes of trueness of detection results in these laboratories were evaluated according to the WS/T 403-2012 standard,and the changes of consistency for ALT and AST before and after measuring value transfer were investigated. Results The results of AMY,ALP,GGT,CK and LDH calibrator,sample 1 and sample 2assigned by the established network were 138. 7 U/L,278. 5 U/L and 68. 3 U/L,265. 3 U/L,94. 5 U/L and 134. 4 U/L,195. 8 U/L,89. 0U/L and 158. 9 U/L,393. 7 U/L,260. 0 U/L and 645. 3 U/L,and 302. 0 U/L,250. 0 U/L and 452. 7 U/L,respectively. The percentages of sample 1 and sample 2 which met the bias requirements of the WS/T 403-2012 standard before measuring value transfer for AMY,ALP and GGT were 65. 9% and 61. 0%,76. 6% and 78. 7%,and 66. 7% and 70. 8%,respectively,while after measuring value transfer,they were89. 2% and 83. 8%,86. 7% and 80. 0%,and 85. 4% and 91. 7%,respectively. The percentages of sample 2 which met the bias requirements of the WS/T 403-2012 standard before measuring value
出处 《临床检验杂志》 CAS CSCD 2017年第2期138-141,148,共5页 Chinese Journal of Clinical Laboratory Science
基金 国家质检公益性行业科研指标(201210066) 北京市科技计划(Z141107006614010)
关键词 量值传递 溯源 参考实验室网络 正确度 measuring value transfer traceability reference laboratory network trueness
  • 相关文献

参考文献4

二级参考文献21

  • 1陈文祥,申子瑜,郭健,杨振华.临床检验量值溯源中的重要术语与概念及有关问题[J].中华检验医学杂志,2005,28(2):142-146. 被引量:35
  • 2中华人民共和国卫生部.临床生物化学检验常规项目分析质量指标[S].WS/T403-2012,中华人民共和国卫生部,2012. 被引量:6
  • 3中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.WS/T352-2011,丙氨酸氨基转移酶催化活性浓度测定(无磷酸吡哆醛)参考方法[s].中华人民共和国卫生部,2011. 被引量:1
  • 4中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.WS/T353-2011,天门冬氨酸氨基转移酶催化活性浓度测定(无磷酸吡哆醛)参考方法[S].中华人民共和国卫生部,2011. 被引量:1
  • 5Ric6s C, Alvarez V, Cava F, et al. Current databases on biologic variation : pros, cons and progress [ J ]. Scand J Clin Lab Invest, 1999,59(7) :491-500. 被引量:1
  • 6Panteghini M, Ceriotti F, Schumann G, et al. Establishing a reference system in clinical enzymology[ J]. Clin Chem Lab Med, 2001,39(9) :795-800. 被引量:1
  • 7Rosalki SB, Bayoumi RA. Activation by pyridoxal 5-phosphate of aspartate transaminase in serum of patients with heart and liver disease[J]. Clin Chim Acta,1975,59(3) :357-360. 被引量:1
  • 8Mastroianni A, Longoni PD, Franzini C, et al. Importance of pyridoxal-5'-Phosphate addition to the assay medium for the measurement of catalytic concentrations of plasma aspartate and alanine aminotransferases in patients undergoing antineoplastic chemotherapy [ J ]. Eur J C1 in Chem Clin Biochem, 1996,34 ( 6 ) : 507-510. 被引量:1
  • 9Mauro Panteghini. Traceability, reference systems and result comparability[ J]. Clin Biochem Rev ,2007,28 ( 8 ) :97-104. 被引量:1
  • 10ISO. ISO 17511:2003, In vitro diagnostic medical devices-measurement of quantities in samples of biological origin-metrologicaltraceability of values assigned to calibrators and control materials.ISO,2003. 被引量:1

共引文献21

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部